Recruitment of osteoclasts induced by TNF-α is central to the inflammatory element of destructive bone diseases [10], and TNF-α-targeted drugs are a known effective tool for suppressing inflammatory bone destruction in diseases such as rheumatoid arthritis [11]. The gene discussed is TNF; the disease is rheumatoid arthritis.